Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 7791-7800 of 13616

Page
per page
  1. Peficitinb (ASP015K, JNJ-54781532)
    B6005 Peficitinb (ASP015K, JNJ-54781532)
    Summary: JAK inhibitor
      ≥23.2 mg/mL
  2. AZD-9291 mesylate
    B1105 AZD-9291 mesylate
    Summary: third generation EGFRm inhibitor, oral and irreversible
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  3. LEE011 hydrochloride
    B1083 LEE011 hydrochloride
    Summary: CDK inhibitor
      ≥12.7 mg/mL
  4. CAY10505
    B2182 CAY10505
    Summary: Potent PI3Kγ inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.45 mg/mL
  5. Phenytoin sodium
    B2272 Phenytoin sodium
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: Sodium channel stabilizer
      insoluble in H2O; insoluble in EtOH; ≥11.55 mg/mL
  6. Repotrectinib
    A4650 Repotrectinib
    Summary: A tyrosine kinase inhibitor for the treatment of ROS1-positive non-small cell lung cancer
      ≥17 mg/mL
  7. 3,4-Dimethoxyphenol
    C6691 3,4-Dimethoxyphenol
    Summary: A plant-derived compound with tyrosinase inhibitory activity, used for skin brightening and antioxidant purposes.
      ≥26.4 mg/mL
  8. (R)-(-)-1,3-Butanediol
    C6695 (R)-(-)-1,3-Butanediol
    Summary: A small-molecule modulator for regulating carbohydrate and lipid metabolism
      ≥16.8 mg/mL
  9. Isovanillin
    C6797 Isovanillin
    Summary: A benzaldehyde derivative with antioxidant, anti-inflammatory, and neuroprotective effects
      ≥26.3 mg/mL
  10. Trastuzumab
    B8790 Trastuzumab
    Summary: A humanized monoclonal antibody for the treatment of HER2-positive breast cancer and gastric cancer

Items 7791-7800 of 13616

Page
per page